NICHE PHARMA

Mark For: NICHE PHARMA™ trademark registration is intended to cover the categories of compositions, formulations and/or medical apparatuses, and the manufacture or distribution thereof, of medicinal drug preparations or medical apparatuses intended for a specific disease entity, whereby said compositions, formulations and medical apparatuses are not deemed market-worthy by large commercial manufacturing concerns because the population needing treatment for said disease entity is not of sufficient size to be commercially attractive relative to larger disease populations, for use in humans and/or animals. [all]

Status

2022-09-09 UTC
⟳ Refresh

DEAD APPLICATION Refused Dismissed or Invalidated

Research	OneLook Acronym Finder
Serial Number	76214938
Mark Literal Elements	NICHE PHARMA
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	FILE REPOSITORY (FRANCONIA) 2002-05-07
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Law Office Assigned	L50
Employee Name	BELL, MARLENE D

Timeline

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Compositions, formulations and/or medical apparatuses, and the manufacture or distribution thereof, of medicinal drug preparations or medical apparatuses intended for a specific disease entity, whereby said compositions, formulations and medical apparatuses are not deemed market-worthy by large commercial manufacturing concerns because the population needing treatment for said disease entity is not of sufficient size to be commercially attractive relative to larger disease populations, for use in humans and/or animals